Amikacin Dosing for a 69-year-old, 68 kg Female with Creatinine 0.9 mg/dL
For this 69-year-old female patient, administer amikacin 680 mg (10 mg/kg) IV once daily, with mandatory therapeutic drug monitoring to guide subsequent dosing.
Rationale for Age-Adjusted Dosing
The patient's age is the critical factor here. For patients greater than 59 years of age, the dose should be reduced to 10 mg/kg per day (maximum 750 mg) 1, 2. This age-based dose reduction is essential because:
- Elderly patients have increased risk of both ototoxicity and nephrotoxicity
- Age is independently associated with higher rates of permanent hearing loss (approximately one-third of patients in some studies) 3
- The risk correlates with cumulative dose and age 3
Calculation Details
- Weight-based dose: 68 kg × 10 mg/kg = 680 mg once daily
- Renal function assessment: With serum creatinine of 0.9 mg/dL in a 74-year-old female weighing 68 kg, the estimated creatinine clearance (Cockcroft-Gault) is approximately 50-60 mL/min, indicating mild renal impairment
- Maximum daily dose: Should not exceed 750 mg in patients >59 years 1, 2
Critical Monitoring Requirements
Therapeutic drug monitoring is mandatory 4:
- Target trough: <5 mg/L (must avoid levels >10 mg/L) 4
- Target peak: 35-45 μg/mL for daily dosing 3
- Timing: Measure trough before next dose; peak 30-90 minutes after infusion 4
- Frequency: Peak level in first week, trough levels weekly for 4 weeks, then can reduce to fortnightly when stable 5
Renal Function Considerations
While her creatinine is 0.9 mg/dL (suggesting borderline renal function for her age), the initial dose should not be reduced further based on renal function alone 6. However:
- Dosing interval adjustment may be needed after therapeutic drug monitoring
- If creatinine clearance is confirmed <60 mL/min, consider extending interval to 15 mg/kg every 36-48 hours after the loading dose 7
- The dose per kilogram should be maintained at 12-15 mg/kg even with renal impairment to preserve concentration-dependent bactericidal effect 1, 2
Safety Monitoring Beyond Drug Levels
Baseline assessments required 1, 2:
- Audiogram and vestibular testing
- Serum creatinine
- Renal function assessment
- Question regarding auditory or vestibular symptoms
- Repeat audiogram if symptoms develop
Common Pitfalls to Avoid
- Do not use standard 15 mg/kg dosing in patients >59 years—this significantly increases toxicity risk
- Do not rely solely on serum creatinine for renal dosing in elderly patients; calculate creatinine clearance 4
- Do not skip therapeutic drug monitoring—elderly patients have unpredictable pharmacokinetics 8, 6
- Limit treatment duration to 7-10 days whenever feasible 4
- Administer as 30-60 minute infusion, not bolus 4
Alternative Approach if Severe Infection
If treating a severe infection where higher peak concentrations are needed, consider 15 mg/kg (approximately 1000 mg) given every 36-48 hours rather than daily dosing 7. This intermittent dosing strategy:
- Achieves higher peaks (target 65-80 μg/mL) 3
- Allows longer drug-free intervals to minimize toxicity
- May be preferable given her age and borderline renal function
The key principle: maintain the milligram dose per kilogram but extend the interval in elderly patients with any degree of renal impairment 1, 2.